Atomwise Inc., the creator of AtomNet, the first Deep Learning technology for novel small molecule discovery raised $45 million of growth funding, led by Monsanto Growth Ventures, DCVC, and B Capital Group.
Tech giant Microsoft and leading Indian speciality hospital, Apollo Hospitals, will work to develop and deploy new machine learning models to predict patient risk for heart disease and assist doctors on treatment plans.
South Korea’s largest biopharmaceutical business association has kickstarted preparations for a support center that will leverage artificial intelligence to help pharmaceutical companies accelerate new drug development processes
BenevolentAI, one of the world’s largest private AI companies, acquired a state-of-the-art drug discovery and development facility on the Babraham Research Campus in Cambridge (UK) for an undisclosed sum.
FarmaTrust, a UK blockchain startup, has officially signed a partnership with the Mongolian government to pilot a one-year project aimed at preventing the creation and distribution of counterfeit medications.
Primer Capital, a venture biotech fund, invested 11 million rubles in TeleMD project. This is a software-based platform that uses artificial intelligence to diagnose and assess the risks of oncological diseases